Literature DB >> 20877914

A multi-pronged search for a common structural motif in the secretion signal of Salmonella enterica serovar Typhimurium type III effector proteins.

Garry W Buchko1, George Niemann, Erin S Baker, Mikhail E Belov, Richard D Smith, Fred Heffron, Joshua N Adkins, Jason E McDermott.   

Abstract

Many pathogenic Gram-negative bacteria use a type III secretion system (T3SS) to deliver effector proteins into the host cell where they reprogram host defenses and facilitate pathogenesis. The first 20-30 N-terminal residues usually contain the 'secretion signal' that targets effector proteins for translocation, however, a consensus sequence motif has never been discerned. Recent machine-learning approaches, such as support vector machine (SVM)-based Identification and Evaluation of Virulence Effectors (SIEVE), have improved the ability to identify effector proteins from genomics sequence information. While these methods all suggest that the T3SS secretion signal has a characteristic amino acid composition bias, it is still unclear if the amino acid pattern is important and if there are any unifying structural properties that direct recognition. To address these issues a peptide corresponding to the secretion signal for Salmonella enterica serovar Typhimurium effector SseJ was synthesized (residues 1-30, SseJ) along with scrambled peptides of the same amino acid composition that produced high (SseJ-H) and low (SseJ-L) SIEVE scores. The secretion properties of these three peptides were tested using a secretion signal-CyaA fusion assay and their structural properties probed using circular dichroism, nuclear magnetic resonance, and ion mobility spectrometry-mass spectrometry. The secretion predictions from SIEVE matched signal-CyaA fusion experimental results with J774 macrophages suggesting that the SseJ secretion signal has some sequence order dependence. The structural studies showed that the SseJ, SseJ-H, and SseJ-L peptides were intrinsically disordered in aqueous solution with a small predisposition to adopt nascent helical structure only in the presence of structure stabilizing agents such as 1,1,1,3,3,3-hexafluoroisopropanol. Intrinsic disorder may be a universal feature of effector secretion signals as similar conclusions were reached following structural characterization of peptides corresponding to the N-terminal regions of the S. Typhimurium effectors SptP, SopD-2, GtgE, and the Yersinia pestis effector YopH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20877914      PMCID: PMC3282560          DOI: 10.1039/c0mb00097c

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  69 in total

1.  Large anhydrous polyalanine ions: evidence for extended helices and onset of a more compact state.

Authors:  A E Counterman; D E Clemmer
Journal:  J Am Chem Soc       Date:  2001-02-21       Impact factor: 15.419

2.  Helix unfolding in unsolvated peptides.

Authors:  B S Kinnear; M R Hartings; M F Jarrold
Journal:  J Am Chem Soc       Date:  2001-06-20       Impact factor: 15.419

3.  The N-terminus of enteropathogenic Escherichia coli (EPEC) Tir mediates transport across bacterial and eukaryotic cell membranes.

Authors:  J Adam Crawford; James B Kaper
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

4.  Crystal structure of the type III effector AvrB from Pseudomonas syringae.

Authors:  Christian C Lee; Michelle D Wood; Kenneth Ng; Carsten B Andersen; Yi Liu; Peter Luginbühl; Glen Spraggon; Fumiaki Katagiri
Journal:  Structure       Date:  2004-03       Impact factor: 5.006

5.  A common structural motif in the binding of virulence factors to bacterial secretion chaperones.

Authors:  Mirjana Lilic; Milos Vujanac; C Erec Stebbins
Journal:  Mol Cell       Date:  2006-03-03       Impact factor: 17.970

6.  Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle.

Authors:  Leslie Bailey; Asa Gylfe; Charlotta Sundin; Sandra Muschiol; Mikael Elofsson; Peter Nordström; Birgitta Henriques-Normark; Raimond Lugert; Anders Waldenström; Hans Wolf-Watz; Sven Bergström
Journal:  FEBS Lett       Date:  2007-01-17       Impact factor: 4.124

7.  The type III secretion chaperone SycE promotes a localized disorder-to-order transition in the natively unfolded effector YopE.

Authors:  Loren Rodgers; Alicia Gamez; Roland Riek; Partho Ghosh
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

Review 8.  Type III secretion systems as targets for novel therapeutics.

Authors:  Vincent T Lee; Jennifer L Kessler
Journal:  IDrugs       Date:  2009-10

9.  YopD and LcrH regulate expression of Yersinia enterocolitica YopQ by a posttranscriptional mechanism and bind to yopQ RNA.

Authors:  Deborah M Anderson; Kumaran S Ramamurthi; Christina Tam; Olaf Schneewind
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

10.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

View more
  27 in total

Review 1.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 2.  Computational prediction of type III and IV secreted effectors in gram-negative bacteria.

Authors:  Jason E McDermott; Abigail Corrigan; Elena Peterson; Christopher Oehmen; George Niemann; Eric D Cambronne; Danna Sharp; Joshua N Adkins; Ram Samudrala; Fred Heffron
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  SepD/SepL-dependent secretion signals of the type III secretion system translocator proteins in enteropathogenic Escherichia coli.

Authors:  Wanyin Deng; Hong B Yu; Yuling Li; B Brett Finlay
Journal:  J Bacteriol       Date:  2015-02-02       Impact factor: 3.490

4.  Outer membrane targeting of secretin PulD protein relies on disordered domain recognition by a dedicated chaperone.

Authors:  Nicholas N Nickerson; Tommaso Tosi; Andréa Dessen; Bruno Baron; Bertrand Raynal; Patrick England; Anthony P Pugsley
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

5.  A Salmonella type three secretion effector/chaperone complex adopts a hexameric ring-like structure.

Authors:  Pierre Roblin; Frédérique Dewitte; Vincent Villeret; Emanuele G Biondi; Coralie Bompard
Journal:  J Bacteriol       Date:  2014-11-17       Impact factor: 3.490

Review 6.  Behind the lines-actions of bacterial type III effector proteins in plant cells.

Authors:  Daniela Büttner
Journal:  FEMS Microbiol Rev       Date:  2016-11-01       Impact factor: 16.408

7.  Bastion3: a two-layer ensemble predictor of type III secreted effectors.

Authors:  Jiawei Wang; Jiahui Li; Bingjiao Yang; Ruopeng Xie; Tatiana T Marquez-Lago; André Leier; Morihiro Hayashida; Tatsuya Akutsu; Yanju Zhang; Kuo-Chen Chou; Joel Selkrig; Tieli Zhou; Jiangning Song; Trevor Lithgow
Journal:  Bioinformatics       Date:  2019-06-01       Impact factor: 6.937

8.  RNA type III secretion signals that require Hfq.

Authors:  George S Niemann; Roslyn N Brown; Ivy T Mushamiri; Nhu T Nguyen; Rukayat Taiwo; Afke Stufkens; Richard D Smith; Joshua N Adkins; Jason E McDermott; Fred Heffron
Journal:  J Bacteriol       Date:  2013-02-08       Impact factor: 3.490

Review 9.  Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads.

Authors:  Coral González-Prieto; Cammie F Lesser
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

10.  Type III-Dependent Translocation of HrpB2 by a Nonpathogenic hpaABC Mutant of the Plant-Pathogenic Bacterium Xanthomonas campestris pv. vesicatoria.

Authors:  Felix Scheibner; Steve Schulz; Jens Hausner; Sylvestre Marillonnet; Daniela Büttner
Journal:  Appl Environ Microbiol       Date:  2016-05-16       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.